Corcept Therapeutics · 1 day ago
Quality Assurance & Regulatory Affairs Intern
Redwood City, CA
Internship
Onsite
Intern
$26/hr - $32/hrCorcept Therapeutics is a leading company in the research and development of cortisol modulators aimed at treating serious diseases. As a Quality Assurance/Regulatory Affairs intern, you will gain exposure to the biopharmaceutical industry and support the QA and RA departments in ensuring compliance with industry standards and regulations.
BiotechnologyMedicalPharmaceutical
No H1B
Responsibilities
Review, analyze and organize complex information and documentation across multiple Good Practice areas, potentially including chemical manufacturing specifications, clinical study reports, pharmacovigilance workflows and regulatory submission components
Shadow QA and RA team members and participate in a range of meetings from weekly team huddles to high-level strategic discussions
Contribute to preparation for regulatory filings and inspection readiness efforts in support of new products
Deliver a department presentation at the end of the program
Participate as a member of the 2026 intern team group project that includes a company-wide presentation
Qualification
Required
Applicants must be currently authorized to work in the United States on a full-time basis
Preferred
Exceptional interpersonal skills with a demonstrated ability to work collaboratively, take initiative and contribute innovative ideas
Strong organizational skills and attention to detail
Ability to quickly identify problems and propose practical solutions
Clear, effective written, verbal and presentation communication skills
Proficiency with Microsoft Office Suite (i.e., Word, Excel, PowerPoint)
Passion for learning and an interest in health care, biotech, pharmaceuticals or life sciences
Must be able to complete at least 10 consecutive weeks between June and August and it is a full-time internship (40 hours per week)
Must be able to work onsite at our Redwood City office for the duration of the internship, no relocation available
Company
Corcept Therapeutics
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.
Founded in 1998
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$119.09MKey Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M
Leadership Team
Roberto Vieira
President, Oncology
Yuan Xu
Associate Director, Statistical Programming
Recent News
2026-01-03
Company data provided by crunchbase